Promising therapies still need to be further evaluated in clinical trials. The first systematic review of trials of possible therapies to slow vascular calcification in chronic kidney disease (CKD) ...

Doctoral students work hand-in-hand with faculty researchers on advances such as a “band-aid” for the heart, non-invasive ...

Vascular calcification, low bone mass and fragility fractures are all frequent age-dependent disorders. Recent clinical and experimental data suggest that vascular calcification and bone loss could ...

Appropriate imaging can help identify patients who need intensive medical treatment. Calcification in the cardiac valves and aorta portends worse survival and progresses faster in patients with ...

Please provide your email address to receive an email when new articles are posted on . In the course of 18 months, supplementation with cholecalciferol did not attenuate vascular calcification ...

Logistic regression is the most cost-effective model for medial vascular calcification classification, with a mean ICER of $278 using five low-cost features. Despite similar diagnostic accuracy, ...

Researchers from Tokyo Medical and Dental University (TMDU) have uncovered a link between cardiovascular disease and chronic kidney disease, revealing novel disease biomarkers and therapeutic targets ...

DUBLIN – Sanifit Therapeutics SA has found a taker for its phase III calcification inhibitor for kidney dialysis patients, SNF-472, in the shape of Vifor Pharma AG, which is acquiring the Spanish ...

A new research paper was published in Aging (Aging-US) Volume 17, Issue 4, on April 2, 2025, titled "Fisetin ameliorates vascular smooth muscle cell calcification via DUSP1-dependent p38 MAPK ...

A collaboration between researchers at FIU’s Herbert Wertheim College of Medicine (HWCOM) and the College of Engineering & Computing (CEC) has resulted in a U.S. patent that could eventually ...